sglt2 inhibitors empagliflozin tablets

Empagreat 10 mg Tablet contains Empagliflozin 10 mg, a prescription medicine used to help manage type 2 diabetes mellitus in adults. It belongs to the SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor class of medicines, which lowers blood sugar by helping the kidneys remove excess glucose through urine. In addition to improving blood sugar control, empagliflozin has proven cardiovascular and kidney benefits in appropriate patients. Empagreat 10 mg is prescribed alongside a healthy diet and regular exercise to achieve better blood glucose control. It may also be recommended to reduce the risk of hospitalization for heart failure and to help slow the progression of chronic kidney disease (CKD) in eligible patients, as determined by a healthcare professional. The tablet is typically taken once daily, with or without food, at the same time each day. It should be swallowed whole with water and taken exactly as prescribed. Staying well hydrated during treatment is important, as the medicine increases the amount of glucose and water excreted through urine. Common side effects may include frequent urination, increased thirst, urinary tract infections (UTIs), genital yeast infections, and mild dehydration. Although uncommon, serious side effects such as diabetic ketoacidosis, severe dehydration, or kidney problems may occur and require immediate medical attention. Patients should seek medical advice if they experience persistent vomiting, severe abdominal pain, fever, or signs of infection. Before using Empagreat 10 mg, inform your doctor if you have kidney disease, liver disease, low blood pressure, recurrent urinary infections, or are pregnant or breastfeeding. Regular monitoring of blood sugar, kidney function, and overall health is recommended throughout treatment to ensure safe and effective diabetes management.